TAMs exhibit functional plasticity, polarizing toward either a pro-inflammatory, antitumor phenotype (M1, CD68-positive) or an anti-inflammatory, tumor-promoting phenotype (M2, CD163-positive). The gene discussed is CD68; the disease is neoplasm.